Zevra Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$9.38

+0.23 (+2.51%)

As of Mar 25, 2:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -43.1% upside

Low Target $3.67

Average Target $5.34

High Target $6.76

Current Price $9.38

Current
$9.38

Target
$5.34

$3.67 $5.34 avg $6.76

Scenario Analysis

Bear Case

$3.67

-60.9%

Low target

Base Case

$5.34

-43.1%

Avg target

Bull Case

$6.76

+-27.9%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$13.16

-28.7% from high

52-Week Low

$6.19

+51.5% from low

Target vs 52W High

$5.34

-59.4% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%